In this Review, the authors synthesize recommendations on the management of neuroimmunological disease in the context of the COVID-19 pandemic. They consider these recommendations alongside the first available data from patients, and provide an overview of management approaches in the COVID-19 era.
- Catharina Korsukewitz
- Stephen W. Reddel
- Heinz Wiendl
